PA21259, SBIR Phase I, Developing a RIG-I agonist to prevent COVID-19
-
Award Number: R43IP001229
-
ORGANIZATION: NATIONAL CENTER FOR ZOONOTIC, VECTOR-BORNE, AND ENTERIC DISEASES
-
OPDIV: CDC
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
-
PERIOD OF PERFORMANCE START DATE: 09/30/2023
-
PERIOD OF PERFORMANCE END DATE: 01/01/2026